BTG Specialty Pharmaceuticals
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Boston_Scientific
|
| gptkbp:acquisitionYear |
2019
|
| gptkbp:formerName |
gptkb:British_Technology_Group
|
| gptkbp:founded |
1946
|
| gptkbp:headquartersLocation |
gptkb:London,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
BTG Specialty Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
Crofab
DigiFab Vistogard Voraxaze |
| gptkbp:parentCompany |
gptkb:Boston_Scientific
|
| gptkbp:specializesIn |
antidotes
critical care medicines emergency care products |
| gptkbp:stockExchange |
gptkb:London_Stock_Exchange
|
| gptkbp:stockSymbol |
BTG (former)
|
| gptkbp:bfsParent |
gptkb:Serb_Pharmaceuticals
|
| gptkbp:bfsLayer |
8
|